AI assistant
Sending…
Boule Diagnostics — Major Shareholding Notification 2016
Oct 3, 2016
3143_iss_2016-10-03_fa910967-1fd8-4d1b-a14f-5559b07b32b9.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Boule Diagnostic AB
Holder
SEB Asset Management S.A.
Instrument
| Instrument | Ordinary stock SE0000437402 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 30/09/2016 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 333,400 | |
| Directly held voting rights | 333,400 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 7.08 % | |
| Directly held voting rights | 7.08 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 7.08 % | 333,400 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 7.08 % | 333,400 |
| Group total holdings | ||
| Voting rights 333,400 |
||
| Percentage of voting rights 7.08 | ||
| Published | ||
| 03/10/2016 16:33 | ||
| Contact | ||
| Phone | +46852229610 Email [email protected] | |
| *Source of information has chosen not to submit the data | ||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Boule Diagnostics
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Interim / Quarterly Report
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Annual Report
2026
Apr 10
Interim / Quarterly Report
2026
Feb 11
Earnings Release
2026
Feb 11
Board/Management Information
2025
Dec 30
Board/Management Information
2025
Dec 30